CN103948970A - 血液透析用体外循环管路及其制备方法 - Google Patents
血液透析用体外循环管路及其制备方法 Download PDFInfo
- Publication number
- CN103948970A CN103948970A CN201410171300.6A CN201410171300A CN103948970A CN 103948970 A CN103948970 A CN 103948970A CN 201410171300 A CN201410171300 A CN 201410171300A CN 103948970 A CN103948970 A CN 103948970A
- Authority
- CN
- China
- Prior art keywords
- hemodialysis
- extracorporeal circulation
- pipeline
- circulation pipeline
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001631 haemodialysis Methods 0.000 title claims abstract description 45
- 230000000322 hemodialysis Effects 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 238000000338 in vitro Methods 0.000 title abstract 6
- 238000000576 coating method Methods 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 24
- 239000011248 coating agent Substances 0.000 claims abstract description 22
- 230000008569 process Effects 0.000 claims abstract description 18
- 238000007765 extrusion coating Methods 0.000 claims abstract description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 40
- 239000000047 product Substances 0.000 claims description 37
- 239000000463 material Substances 0.000 claims description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- 238000011017 operating method Methods 0.000 claims description 12
- 239000003146 anticoagulant agent Substances 0.000 claims description 10
- 229940127219 anticoagulant drug Drugs 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 239000003208 petroleum Substances 0.000 claims description 9
- 238000006116 polymerization reaction Methods 0.000 claims description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims description 8
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 6
- 150000003254 radicals Chemical class 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 4
- -1 2,2'-Azobis(2,4-dimethylvaleronitrile) radical Chemical class 0.000 claims description 3
- 239000003999 initiator Substances 0.000 claims description 3
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 claims description 2
- LDCRTTXIJACKKU-ONEGZZNKSA-N dimethyl fumarate Chemical compound COC(=O)\C=C\C(=O)OC LDCRTTXIJACKKU-ONEGZZNKSA-N 0.000 claims 1
- 229960004419 dimethyl fumarate Drugs 0.000 claims 1
- 230000010100 anticoagulation Effects 0.000 abstract description 10
- 208000007536 Thrombosis Diseases 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 230000023555 blood coagulation Effects 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 2
- 210000001772 blood platelet Anatomy 0.000 abstract 2
- 239000002585 base Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 108010049003 Fibrinogen Proteins 0.000 description 4
- 102000008946 Fibrinogen Human genes 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 229940012952 fibrinogen Drugs 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 4
- 229920001427 mPEG Polymers 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000004154 complement system Effects 0.000 description 2
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- NGQQUXXTDZADNX-UHFFFAOYSA-N 2,3,4,5-tetrachlorofuran Chemical compound ClC=1OC(Cl)=C(Cl)C=1Cl NGQQUXXTDZADNX-UHFFFAOYSA-N 0.000 description 1
- HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical compound COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- 101150045640 VWF gene Proteins 0.000 description 1
- 108010031318 Vitronectin Proteins 0.000 description 1
- 102100035140 Vitronectin Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000002965 anti-thrombogenic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102100036537 von Willebrand factor Human genes 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410171300.6A CN103948970B (zh) | 2014-04-28 | 2014-04-28 | 血液透析用体外循环管路及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410171300.6A CN103948970B (zh) | 2014-04-28 | 2014-04-28 | 血液透析用体外循环管路及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103948970A true CN103948970A (zh) | 2014-07-30 |
CN103948970B CN103948970B (zh) | 2016-08-10 |
Family
ID=51326405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410171300.6A Active CN103948970B (zh) | 2014-04-28 | 2014-04-28 | 血液透析用体外循环管路及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103948970B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109172877A (zh) * | 2018-08-28 | 2019-01-11 | 杭州创元医疗科技有限公司 | 一种仿生抗凝血乳液及其制备方法和使用方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050169957A1 (en) * | 2002-12-11 | 2005-08-04 | Hossainy Syed F. | Biocompatible polyacrylate compositions for medical applications |
CN101879335A (zh) * | 2010-07-07 | 2010-11-10 | 中国人民解放军第四军医大学 | 氧化低分子量肝素-抗凝血酶复合物制备方法和应用 |
CN103721300A (zh) * | 2013-12-19 | 2014-04-16 | 华中科技大学 | 一种抗凝血涂层材料及其制备方法 |
-
2014
- 2014-04-28 CN CN201410171300.6A patent/CN103948970B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050169957A1 (en) * | 2002-12-11 | 2005-08-04 | Hossainy Syed F. | Biocompatible polyacrylate compositions for medical applications |
CN101879335A (zh) * | 2010-07-07 | 2010-11-10 | 中国人民解放军第四军医大学 | 氧化低分子量肝素-抗凝血酶复合物制备方法和应用 |
CN103721300A (zh) * | 2013-12-19 | 2014-04-16 | 华中科技大学 | 一种抗凝血涂层材料及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109172877A (zh) * | 2018-08-28 | 2019-01-11 | 杭州创元医疗科技有限公司 | 一种仿生抗凝血乳液及其制备方法和使用方法 |
CN109172877B (zh) * | 2018-08-28 | 2021-07-13 | 杭州忻元医疗科技合伙企业(有限合伙) | 一种仿生抗凝血乳液及其制备方法和使用方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103948970B (zh) | 2016-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5550732B2 (ja) | 血小板豊富血漿(prp)を活性化して組織再生を誘導する組成物及びその製造方法 | |
Li et al. | Modification of polyethersulfone hemodialysis membrane by blending citric acid grafted polyurethane and its anticoagulant activity | |
Ma et al. | Toward highly blood compatible hemodialysis membranes via blending with heparin-mimicking polyurethane: Study in vitro and in vivo | |
Tong et al. | Preparation, blood compatibility and anticoagulant effect of heparin-loaded polyurethane microspheres | |
Liu et al. | Surface characteristics and hemocompatibility of PAN/PVDF blend membranes | |
Zhang et al. | Proteomic analysis of MSC‐derived apoptotic vesicles identifies Fas inheritance to ameliorate haemophilia a via activating platelet functions | |
US20050239131A1 (en) | Interactive system for presenting and eliminating substances | |
JP2007130194A (ja) | 医療用材料 | |
Liu et al. | Antibody‐free hydrogel with the synergistic effect of cell imprinting and boronate affinity: toward the selective capture and release of undamaged circulating tumor cells | |
CN108939941B (zh) | 一种具有抗凝血功能的pvdf平板分离膜 | |
WO2018047929A1 (ja) | 血液浄化用の材料 | |
Wang et al. | Blood compatibility of a new zwitterionic bare metal stent with hyperbranched polymer brushes | |
CN103948970A (zh) | 血液透析用体外循环管路及其制备方法 | |
O'Rourke et al. | Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application | |
CN106110899B (zh) | 一种制备二氧化碳响应性膜的方法 | |
Peng et al. | Controllable polyvinylpyrrolidone modified Polystyrene divinylbenzene for efficient adsorption of bilirubin and improvement of hemocompatibility | |
Wang et al. | Antifouling and blood‐compatible poly (ether sulfone) membranes modified by zwitterionic copolymers via In situ crosslinked copolymerization | |
CN108291202A (zh) | 牛血清组合物和使用所述牛血清组合物作为添加剂培养细胞的方法 | |
CN102344534A (zh) | 含扑热息痛结构的聚甲基聚乙二醇丙烯酸酯及其制备方法和使用方法 | |
CN109745580B (zh) | 抗凝血多肽和细胞黏附多肽共修饰的小口径人工血管及制备方法 | |
CN110629321B (zh) | 一种抗凝血溶纤纳米纤维材料的制备方法 | |
Li et al. | One‐pot synthesized poly (vinyl pyrrolidone‐co‐methyl methacrylate‐co‐acrylic acid) blended with poly (ether sulfone) to prepare blood‐compatible membranes | |
CN102344521A (zh) | 含单硝酸山梨醇酯结构的聚甲基聚乙二醇丙烯酸酯及其制备方法和使用方法 | |
CN105112373A (zh) | 一种溶血性贫血患者外周血单核细胞的分离方法 | |
Mulvihill et al. | Evaluation of haemodialysis membrane biocompatibility by parallel assessment in an ex vivo model in healthy volunteers. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 213025 98 Fu Min Road, Qishuyan Economic Development Zone, Changzhou, Jiangsu Patentee after: CHANGZHOU DSB MEDICAL CO.,LTD. Address before: 213025 98 Fu Min Road, Qishuyan Economic Development Zone, Changzhou, Jiangsu Patentee before: CHANGZHOU DSB MEDICAL Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Extracorporeal circulation tubing and its preparation method for hemodialysis Effective date of registration: 20231229 Granted publication date: 20160810 Pledgee: Industrial and Commercial Bank of China Limited Changzhou Economic Development Zone sub branch Pledgor: CHANGZHOU DSB MEDICAL CO.,LTD. Registration number: Y2023980075605 |